Jan 19, 2024
January 26, 2025
This week’s newsletter included:
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
- First Patient Enrolled in Merit Medical’s MOTION Study
- bioMérieux Acquires LUMED
- Proposal to Restore R&D Expensing
- ACTION ALERT: Act Now to Restore Immediate R&D Expensing
- Medical Device Track from the 2023 Utah Life Sciences Summit
- Renalytix Update on kidneyIntelX.dkd LCD Consideration
- Utah Life Sciences Innovation Caucus Breakfast
- Life Sciences Day on Capitol Hill
Featured New Member Deal: Chubb
Recent News
- Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer
- Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
- Improving Women’s Health: MobileODT Joins Liger Medical
- Wasatch Health Announces Structured Capital Fund
- Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
- Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
